| Khung thời gian | Giá dự đoán | Quá khứ | lịch sử | Cái nhìn thấu suốt |
|---|---|---|---|---|
| Ngày mai | $6.30 ▲ +1.33% | Hôm qua | $6.19 ▼ -0.56% | Tomorrow's Taysha Gene Therapies Inc. Common Stock (TSHA) setup is anchored to $6.22 and targets $6.30 (+1.33%). The near-term read is upside; watch $6.41 / $6.03 because daily realized volatility is about 6.84%. |
Tomorrow's Taysha Gene Therapies Inc. Common Stock (TSHA) setup is anchored to $6.22 and targets $6.30 (+1.33%). The near-term read is upside; watch $6.41 / $6.03 because daily realized volatility is about 6.84%. | ||||
| Tuần | $6.48 ▲ +4.12% | Tuần trước | $6.11 ▼ -1.73% | The 7-day Taysha Gene Therapies Inc. Common Stock model moves from $6.11 to $6.48 (+4.12%). It gives upside momentum context for this stock, so breaks around $6.41 / $6.03 matter more than a single tick. |
The 7-day Taysha Gene Therapies Inc. Common Stock model moves from $6.11 to $6.48 (+4.12%). It gives upside momentum context for this stock, so breaks around $6.41 / $6.03 matter more than a single tick. | ||||
| Tháng | $6.77 ▲ +8.79% | Tháng trước | $5.99 ▼ -3.69% | The 1-month Taysha Gene Therapies Inc. Common Stock target is $6.77 (+8.79%), compared with the live reference near $6.22. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Taysha Gene Therapies Inc. Common Stock target is $6.77 (+8.79%), compared with the live reference near $6.22. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Năm | $7.20 ▲ +15.77% | Năm ngoái | $5.81 ▼ -6.62% | The 1-year Taysha Gene Therapies Inc. Common Stock scenario points to $7.20 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Taysha Gene Therapies Inc. Common Stock scenario points to $7.20 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 năm | $8.22 ▲ +32.14% | 5 năm trước | $5.38 ▼ -13.50% | The 5-year Taysha Gene Therapies Inc. Common Stock view is $8.22 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Taysha Gene Therapies Inc. Common Stock view is $8.22 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Chỉ số | Giá trị | Tín hiệu |
|---|---|---|
| Price | $6.22 | Mid |
| Daily Change | -3.71% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 65% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $6.22 | Daily Change | -3.71% |
| Market Cap | $1.79B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.